We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$97.3B
AUM Growth
+$5.53B
Cap. Flow
+$1.37B
Cap. Flow %
1.41%
Top 10 Hldgs %
9.68%
Holding
3,734
New
508
Increased
1,623
Reduced
1,169
Closed
410

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$707M
2
JNJ icon
Johnson & Johnson
JNJ
+$396M
3
AMZN icon
Amazon
AMZN
+$312M
4
WMT icon
Walmart Inc
WMT
+$285M
5
ISRG icon
Intuitive Surgical
ISRG
+$262M

Sector Composition

Rank Sector Weight
1 Healthcare 17.73%
2 Technology 14.98%
3 Financials 10.9%
4 Consumer Discretionary 8.96%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQ
3201
DELISTED
Aquantia Corp. Common Stock
AQ
$148K ﹤0.01%
+11,600
New +$146K
PGLC
3202
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$148K ﹤0.01%
122,186
+73,786
+152% +$100K
CENX icon
3203
Century Aluminum
CENX
$4.44B
$147K ﹤0.01%
12,300
-32,700
-73% -$421K
TTNP
3204
DELISTED
Titan Pharmaceuticals
TTNP
$146K ﹤0.01%
196
+16
+9% +$43.5K
AIFC
3205
AI Financial Corp
AIFC
$52.1M
$145K ﹤0.01%
31,200
-1,300
-4% -$5.4K
OPBK icon
3206
OP Bancorp
OPBK
$235M
$143K ﹤0.01%
+12,300
New +$154K
DTRM
3207
DELISTED
Determine, Inc. Common Stock
DTRM
$142K ﹤0.01%
208,933
+22,901
+12% +$24.5K
CRVO icon
3208
CervoMed
CRVO
$23.3M
$139K ﹤0.01%
286
+99
+53% +$46K
MOTS
3209
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$139K ﹤0.01%
+91
New +$173K
INAP
3210
DELISTED
Internap Corporation
INAP
$138K ﹤0.01%
10,948
-34,982
-76% -$433K
RNTX
3211
Rein Therapeutics
RNTX
$65.7M
$137K ﹤0.01%
+2,487
New +$167K
NEGG icon
3212
Newegg Commerce
NEGG
$270M
$136K ﹤0.01%
501
-343
-41% -$93.8K
ESEA icon
3213
Euroseas
ESEA
$560M
$135K ﹤0.01%
16,376
+2,796
+21% +$29.5K
TLF icon
3214
Tandy Leather Factory
TLF
$19.5M
$135K ﹤0.01%
18,300
-800
-4% -$6.11K
HYGS
3215
DELISTED
Hydrogenics Corp
HYGS
$133K ﹤0.01%
+18,300
New +$119K
ACGN
3216
DELISTED
Aceragen Inc
ACGN
$132K ﹤0.01%
+874
New +$125K
BPTH
3217
DELISTED
Bio-Path Holdings Inc
BPTH
$131K ﹤0.01%
554
+57
+11% +$30.8K
PLM
3218
DELISTED
PolyMet Mining Corp.
PLM
$130K ﹤0.01%
+12,720
New +$111K
SPRO icon
3219
Spero Therapeutics
SPRO
$69.5M
$126K ﹤0.01%
+12,000
New +$139K
FWP
3220
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$126K ﹤0.01%
7,914
-3,543
-31% -$69.5K
AAME icon
3221
Atlantic American Corp
AAME
$31.6M
$124K ﹤0.01%
49,500
+200
+0.4% +$524
MTNB icon
3222
Matinas BioPharma
MTNB
$2.03M
$124K ﹤0.01%
2,698
+2,064
+326% +$44.4K
REPX icon
3223
Riley Exploration Permian
REPX
$727M
$124K ﹤0.01%
8,910
+3,603
+68% +$46.2K
CALA
3224
DELISTED
Calithera Biosciences, Inc
CALA
$124K ﹤0.01%
1,179
-6,901
-85% -$657K
NSYS icon
3225
Nortech Systems
NSYS
$37.7M
$123K ﹤0.01%
29,900
+4,300
+17% +$16.8K

Similar funds

Renaissance Technologies's Q3 2018 Portfolio in Review

As of Q3 2018, Renaissance Technologies held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Renaissance Technologies's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Renaissance Technologies's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
  • Renaissance Technologies added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
  • Renaissance Technologies's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
  • Renaissance Technologies fully exited Apple in Q3 2018, selling an estimated $707M.
  • Renaissance Technologies's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
  • Renaissance Technologies opened 508 new positions and closed 410 in Q3 2018.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $97.3B.

Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.